Balyasny Asset Management’s Science Strategic Acquisition Corp. Alpha Warrant SSAAW Stock Holding History

Balyasny Asset Management’s Portfolio SSAAW Stock Details SSAAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66,666	Closed	-$4K	–	3485
2022 Q3	$4K	Hold	66,666	–	–	﹤0.01%	2739
2022 Q2	$6K	Hold	66,666	–	–	﹤0.01%	2644
2022 Q1	$15K	Hold	66,666	–	–	﹤0.01%	2382
2021 Q4	$36K	Hold	66,666	–	–	﹤0.01%	2107
2021 Q3	$47K	Hold	66,666	–	–	﹤0.01%	1783
2021 Q2	$60K	Hold	66,666	–	–	﹤0.01%	1848
2021 Q1	$40K	Buy	+66,666	New	+$41.5K	﹤0.01%	1690

Balyasny Asset Management's SSAAW Position: Q4 2022 in Review

Balyasny Asset Management sold out of Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) in Q4 2022, closing a stake of 66,666 shares — an estimated $4K sold.

Balyasny Asset Management first reported a position in SSAAW in Q1 2021 and held it in 7 quarters. The position peaked at $60K in Q2 2021. 0 funds tracked by Wall St. Rank hold SSAAW as of Q4 2022.

Balyasny Asset Management reported no remaining Science Strategic Acquisition Corp. Alpha Warrant position as of Q4 2022 after selling out during the quarter.
Balyasny Asset Management sold 66,666 Science Strategic Acquisition Corp. Alpha Warrant shares in Q4 2022, an estimated $4K.
Balyasny Asset Management first reported a position in Science Strategic Acquisition Corp. Alpha Warrant in Q1 2021 and held it in 7 quarters.
Balyasny Asset Management's Science Strategic Acquisition Corp. Alpha Warrant position peaked at $60K in Q2 2021.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Warrant as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.